Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
911.01%Stock Based Compensation Margin
VS
Market
Sector
Industry
History
$ 9.42Close
$ 8.77 - $ 25.14 52-Week Range
Ticker Information
Ticker
RNACCompany Name
CARTESIAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCARTESIAN THERAPEUTICS INC - Stock Based Compensation Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RNAC - SB Comp % Historical data
| Date | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
|---|---|---|---|
| 6/30/2025 | $ 1.03M | $ 9.35M | 911.01% |
| 3/31/2025 | $ 34.17M | $ 7.66M | 22.41% |
| 12/31/2024 | $ 38.91M | $ 6.58M | 16.91% |
| 9/30/2024 | $ 47.94M | $ 18.86M | 39.34% |
| 6/30/2024 | $ 54.1M | $ 19.49M | 36.02% |
| 3/31/2024 | $ 25.91M | $ 21.68M | 83.68% |
| 12/31/2023 | $ 26M | $ 22.52M | 86.62% |
| 9/30/2023 | $ 34.53M | $ 10.66M | 30.86% |
| 6/30/2023 | $ 48.69M | $ 10.94M | 22.46% |
| 3/31/2023 | $ 82.72M | $ 10.72M | 12.96% |
Key Performance Insights, Last 5 Years
- CARTESIAN THERAPEUTICS INC's latest trailing twelve months (TTM) SB Comp % stands at 49.67%.
- Over the past 5 years, CARTESIAN THERAPEUTICS INC's average SB Comp % has been 71.64%.
- The median SB Comp % for CARTESIAN THERAPEUTICS INC during this period was 21.68%
- CARTESIAN THERAPEUTICS INC reached its highest SB Comp % over the past 5 years at 911.01%.
- The lowest SB Comp % recorded by CARTESIAN THERAPEUTICS INC in the same timeframe 8.05%
CARTESIAN THERAPEUTICS INC's SB Comp % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp % Benchmarks
Similar metrics to SB Comp %:
- Stock Based Compensation - [Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
Definition of Stock Based Compensation Margin
[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].SB Comp. / Revenues
(=) SB Comp % SB Comp % for CARTESIAN THERAPEUTICS INC is calculated as follows: SB Comp. [ $ 5.61M ] / Revenues [ $ 11.3M ]
(=) SB Comp % [ 49.67% ] RNAC - Stock Based Compensation Margin, Last 5 years
8.05%
Minimum
Mar 31, 2022
911.01%
Maximum
Jun 30, 2025
71.64%
Average
21.68%
Median
SB Comp % Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
| filtered constituents | 2.98K |
|---|---|
| min | -3.97% |
| max | 8.43% |
| average | 1.72% |
| median | 1.04% |
| std | 1.9% |